Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2016 - 2018)

Historic Gains from Investment Securities for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q4 2018 value amounting to $337000.0.

  • Armata Pharmaceuticals' Gains from Investment Securities changed N/A to $337000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was -$25750.0, marking a year-over-year increase of 9290.14%. This contributed to the annual value of $10.8 million for FY2024, which is 29844.44% up from last year.
  • Armata Pharmaceuticals' Gains from Investment Securities amounted to $337000.0 in Q4 2018.
  • In the past 5 years, Armata Pharmaceuticals' Gains from Investment Securities ranged from a high of $1.1 million in Q3 2017 and a low of -$362750.0 during Q2 2015
  • Moreover, its 4-year median value for Gains from Investment Securities was $207208.0 (2016), whereas its average is $203181.6.
  • As far as peak fluctuations go, Armata Pharmaceuticals' Gains from Investment Securities skyrocketed by 36303.42% in 2017, and later plummeted by 9679.02% in 2018.
  • Quarter analysis of 4 years shows Armata Pharmaceuticals' Gains from Investment Securities stood at $547181.0 in 2015, then tumbled by 95.17% to $26419.0 in 2016, then soared by 3952.28% to $1.1 million in 2017, then plummeted by 68.52% to $337000.0 in 2018.
  • Its Gains from Investment Securities was $337000.0 in Q4 2018, compared to $36500.0 in Q3 2018 and $36500.0 in Q2 2018.